Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Holmdahl, R.
Right arrow Articles by Larsson, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Holmdahl, R.
Right arrow Articles by Larsson, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 British Society for Rheumatology

Oestrogen is a Potent Immunomodulator of Murine Experimental Rheumatoid Disease

R. Holmdahl, H. Carlsten*, Liselotte Jansson and P. Larsson

Department of Medical and Physiological Chemistry, Uppsala University Uppsala
* Departments of Medical Microbiology and Rheumatology, Göteborg University Göteborg, Sweden

Correspondence to Dr. Holmdahl, Department of Medical and Physiological Chemistry, Box 575, Uppsala University, S-75123 Uppsala, Sweden


   Abstract

Oestrogen has important modulatory effects on autoimmune diseases. Earlier studies, both in humans and in experimental models, have convincingly suggested that oestrogen exaggerates lupus disease and enhances autoantibody production in lupus. However, a general effect by oestrogen to stimulate autoimmune disease does not fit with recent findings in human rheumatoid arthritis and in certain experimental autoimmune models. Here it is shown that oestrogen treatment suppresses development of type II collagen induced arthritis in mice and rats, which is aT-cell dependent experimental model for human RA. The oestrogen-mediated effects are obtainable in physiological levels and both incidence and severity of disease can be suppressed. It is demonstrated that oestrogen has a dualistic effect on the immune system by suppressing antigen-specific T-cell dependent immune reactions while enhancing B-cell activities. On these grounds, we suggest that autoimmune diseases should be divided into two groups, one in which oestrogen accelerates disease progression and another in which oestrogen is beneficial.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.